4th Quarter - Report

OGR for PFIZER INC

Firm
OGR
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Resolution (S.Con.Res.14)/Budget Reconciliation (H.R.5376). Issues related to COVID-19 response including vaccines and anti-viral therapies. FDA provisions related to prescription drugs; FY2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.4356/S.2599). Issues related drug supply chain; H.R.3927/S.2082, MADE in America Act.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 14 (117th), S. 2599 (117th), H.R. 3927 (117th), H.R. 3 (117th), H.R. 5376 (117th), S. 2082 (117th), H.R. 4356 (117th)

Medicare/Medicaid MMM

Medicare Part D Program; S.912/H.R.1978, Protecting Seniors Through Immunization Act of 2021.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1978 (117th), S. 912 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.